Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Sample name: the product of the invention (batch number P-110201, specification 0.6g) Preparing a compatible injection: 0.9% sodium chloride injection, manufactured by Chongqing Di kang Yangtze pharmaceutical Co., Ltd 5% glucose injection, manufactured by Tai Ji southwest pharmaceutical industries, Ltd 10% glucose injection, manufactured by Tai Ji southwest pharmaceutical industries, Ltd Water for injection, made by Investigation time: 0h, 2h, 4h and 6h And (4) investigation indexes are as follows: the results of the product of the invention in four injections at ambient temperature conditions (dilution to measured concentration, measured only at 0h, 2h, 4h, 6 h) for clarity, pH, visible foreign matter, insoluble particles, related substances (area normalization) are shown in tables 7-8
[PubMed] [Elsevier] Kanjwal Y, Kosinski D, Grubb BP
Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis
the study subjects were not clearly diagnosed with DOR/POR, or the study population was highly heterogeneous
